22nw, LP: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1694297) · Explore on the interactive board
22nw, LP disclosed 14 US equity positions worth $104.7m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is NSP at 19.5% of the reported book, followed by NKTR, SRI. The top ten holdings are 94.6% of the book, and the portfolio behaves like about 8 equal-weight positions. Versus the prior filing it opened 1 new position, added to 1, reduced 1 and exited 3. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does 22nw, LP own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 1 new, 1 added, 1 reduced, 3 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | NSP INSPERITY INC | Industrials | 19.5% | $20.4m | 493,000 | 0% | held |
| 2 | NKTR NEKTAR THERAPEUTICS | Healthcare | 18.7% | $19.6m | 281,115 | 0% | held |
| 3 | SRI STONERIDGE INC | Consumer Cyclical | 17.3% | $18.1m | 2,466,975 | 0% | held |
| 4 | FOXF FOX FACTORY HLDG CORP | Consumer Cyclical | 11.0% | $11.5m | 678,165 | 0% | held |
| 5 | CMT CORE MOLDING TECHNOLOGIES IN | 6.2% | $6.5m | 273,521 | 23% | added | |
| 6 | RGNX REGENXBIO INC | Healthcare | 5.6% | $5.9m | 492,759 | 0% | held |
| 7 | CULP CULP INC | 5.5% | $5.8m | 1,859,061 | 0% | held | |
| 8 | RZLT REZOLUTE INC | 4.1% | $4.3m | 820,653 | 0% | held | |
| 9 | UFI UNIFI INC | Consumer Cyclical | 3.9% | $4.0m | 852,455 | 0% | held |
| 10 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 2.9% | $3.1m | 113,840 | -74% | reduced |
| 11 | TISI TEAM INC | 2.8% | $2.9m | 170,187 | 0% | held | |
| 12 | ELDN ELEDON PHARMACEUTICALS INC | 2.4% | $2.5m | 636,364 | 0% | held | |
| 13 | TBCH TURTLE BEACH CORP | Technology | 0.2% | $179.7k | 14,430 | – | new |
| 14 | LFCR LIFECORE BIOMEDICAL INC | Healthcare | 0.0% | $6.2k | 1,254 | 0% | held |
What did 22nw, LP sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| FSTR FOSTER L B CO | 87.7% | $29.8m |
| FB1 FARMER BROS CO | 7.3% | $2.5m |
| PHENIXFIN CORP | 5.0% | $1.7m |
Sector mix
| Sector | Weight |
|---|---|
| Consumer Cyclical | 32.1% |
| Healthcare | 27.3% |
| Industrials | 19.5% |
| Technology | 0.2% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is 22nw, LP's portfolio?
Across every quarter 22nw, LP has filed, its median largest position is 19.9% of the book and its median top-ten weight is 92.4%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 3.0 completed holding spells, the median lasted 1.0 quarters; 14.0 positions are still open and their final length is unknown.